RxNorm Semantic Concepts Index - 269
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "269".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 26900 | HDL2 - High density lipoprotein subfraction 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26900 | HDL2 - High density lipoprotein subfraction 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26900 | HDL2 - High density lipoprotein subfraction 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26900 | HDL2 - High density lipoprotein subfraction 2 | Designated preferred name (PT) | NO | |
| RxCUI: 26900 | HDL2 - High density lipoprotein subfraction 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 2690197 | Antibody to cancer antigen 125 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690197 | Antibody to cancer antigen 125 | Full form of descriptor (FN) | NO | |
| RxCUI: 2690197 | Antibody to cancer antigen 125 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690197 | Antibody to cancer antigen 125 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690197 | Antibody to cancer antigen 125 | Designated preferred name (PT) | NO | |
| RxCUI: 2690198 | Histamine dihydrochloride 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2690198 | Histamine dihydrochloride 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2690199 | Guaifenesin- and levomenthol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2690199 | Guaifenesin- and levomenthol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2690200 | Guaifenesin- and levomenthol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690200 | Guaifenesin- and levomenthol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690201 | Arrowroot | Designated preferred name (PT) | NO | |
| RxCUI: 2690201 | Arrowroot | Full form of descriptor (FN) | NO | |
| RxCUI: 2690202 | Ascorbic acid 1 g and zinc citrate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690202 | Ascorbic acid 1 g and zinc citrate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690203 | Ascorbic acid- and zinc citrate-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2690203 | Ascorbic acid- and zinc citrate-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2690204 | Ascorbic acid- and zinc citrate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690204 | Ascorbic acid- and zinc citrate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690205 | Calcium ascorbate dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2690205 | Calcium ascorbate dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2690206 | Calcium carbonate 1.5 g and colecalciferol 25 microgram orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690206 | Calcium carbonate 1.5 g and colecalciferol 25 microgram orodispersible tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690206 | Calcium carbonate 1.5 g and colecalciferol 25 microgram orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690207 | Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2690207 | Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690207 | Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2690208 | Calcium carbonate 500 mg and colecalciferol 20 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690208 | Calcium carbonate 500 mg and colecalciferol 20 microgram oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690208 | Calcium carbonate 500 mg and colecalciferol 20 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690209 | Calcium chloride 200 microgram/mL and glucose 50 mg/mL and potassium chloride 300 microgram/mL and sodium chloride 6 mg/mL and sodium lactate 3.1 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2690209 | Calcium chloride 200 microgram/mL and glucose 50 mg/mL and potassium chloride 300 microgram/mL and sodium chloride 6 mg/mL and sodium lactate 3.1 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2690210 | Calcium chloride- and glucose- and potassium chloride- and sodium chloride- and sodium lactate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690210 | Calcium chloride- and glucose- and potassium chloride- and sodium chloride- and sodium lactate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690211 | Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690211 | Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690211 | Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690212 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2690212 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690212 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2690213 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690213 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690213 | Calcium gluconate- and colecalciferol- and nicotinic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690214 | Adeno-associated virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690214 | Adeno-associated virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690214 | Adeno-associated virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690214 | Adeno-associated virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2690214 | Adeno-associated virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690214 | Adeno-associated virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2690215 | Dextromethorphan 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL and triprolidine hydrochloride 250 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2690215 | Dextromethorphan 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL and triprolidine hydrochloride 250 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2690216 | Dextromethorphan hydrobromide 1.3 mg/mL and diphenhydramine hydrochloride 2.8 mg/mL and levomenthol 400 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2690216 | Dextromethorphan hydrobromide 1.3 mg/mL and diphenhydramine hydrochloride 2.8 mg/mL and levomenthol 400 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2690217 | Dextromethorphan- and diphenhydramine- and levomenthol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2690217 | Dextromethorphan- and diphenhydramine- and levomenthol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2690218 | Dextromethorphan- and diphenhydramine- and levomenthol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690218 | Dextromethorphan- and diphenhydramine- and levomenthol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690219 | Pearl barley | Designated preferred name (PT) | NO | |
| RxCUI: 2690219 | Pearl barley | Full form of descriptor (FN) | NO | |
| RxCUI: 2690220 | Quinoa | Designated preferred name (PT) | NO | |
| RxCUI: 2690220 | Quinoa | Full form of descriptor (FN) | NO | |
| RxCUI: 2690221 | Povidone iodine-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690221 | Povidone iodine-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690223 | Product containing ripasudil in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2690223 | Product containing ripasudil in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2690224 | Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral lyophilisate (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2690224 | Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral lyophilisate (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2690225 | SARS coronavirus main proteinase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2690225 | SARS coronavirus main proteinase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2690226 | Sago | Designated preferred name (PT) | NO | |
| RxCUI: 2690226 | Sago | Full form of descriptor (FN) | NO | |
| RxCUI: 2690228 | Product containing precisely tralokinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2690228 | Product containing precisely tralokinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2690229 | Sodium valproate 1 g prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690229 | Sodium valproate 1 g prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690229 | Sodium valproate 1 g prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2690230 | Sodium valproate 150 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690230 | Sodium valproate 150 mg gastro-resistant oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690230 | Sodium valproate 150 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690231 | Product containing precisely vigabatrin 500 milligram/1 sachet granules for conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2690231 | Product containing precisely vigabatrin 500 milligram/1 sachet granules for conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2690232 | Whole grain barley | Designated preferred name (PT) | NO | |
| RxCUI: 2690232 | Whole grain barley | Full form of descriptor (FN) | NO | |
| RxCUI: 2690233 | Insulin degludec 100 unit/mL and liraglutide 3.6 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2690233 | Insulin degludec 100 unit/mL and liraglutide 3.6 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2690234 | Interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2690234 | Interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2690236 | Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2690236 | Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2690237 | Lauromacrogol 400-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2690237 | Lauromacrogol 400-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2690238 | Lenalidomide 7.5 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2690238 | Lenalidomide 7.5 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2690239 | Antibody to Lentivirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690239 | Antibody to Lentivirus | Full form of descriptor (FN) | NO | |
| RxCUI: 2690239 | Antibody to Lentivirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690239 | Antibody to Lentivirus | Designated preferred name (PT) | NO | |
| RxCUI: 2690240 | Lercanidipine hydrochloride hemihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2690240 | Lercanidipine hydrochloride hemihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2690241 | Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2690241 | Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2690242 | Lysergic acid | Designated preferred name (PT) | NO | |
| RxCUI: 2690242 | Lysergic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2690243 | Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690243 | Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690244 | Mixed venous plasma | Designated preferred name (PT) | NO | |
| RxCUI: 2690244 | Mixed venous plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 2690245 | Natalizumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2690245 | Natalizumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2690246 | Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2690246 | Pancreatic amylase 16000 unit and pancreatic lipase 20000 unit and pancreatic protease 1200 unit gastro-resistant oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2690247 | Pancreatic amylase 36 unit/mg and pancreatic lipase 50 unit/mg and pancreatic protease 2 unit/mg gastro-resistant oral granules | Designated preferred name (PT) | NO | |
| RxCUI: 2690247 | Pancreatic amylase 36 unit/mg and pancreatic lipase 50 unit/mg and pancreatic protease 2 unit/mg gastro-resistant oral granules | Full form of descriptor (FN) | NO | |
| RxCUI: 2690248 | Sodium valproate 150 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2690248 | Sodium valproate 150 mg prolonged-release oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690248 | Sodium valproate 150 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2690249 | Sodium valproate 300 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690249 | Sodium valproate 300 mg gastro-resistant oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690249 | Sodium valproate 300 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690250 | Sodium valproate 300 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2690250 | Sodium valproate 300 mg prolonged-release oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690250 | Sodium valproate 300 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2690251 | Sodium valproate 500 mg prolonged-release oral granules sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690251 | Sodium valproate 500 mg prolonged-release oral granules sachet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690251 | Sodium valproate 500 mg prolonged-release oral granules sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2690252 | Sodium valproate 60 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2690252 | Sodium valproate 60 mg/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690252 | Sodium valproate 60 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2690253 | Sodium valproate 600 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690253 | Sodium valproate 600 mg gastro-resistant oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690253 | Sodium valproate 600 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690254 | Cladonia cristatella whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690255 | polyurethane-39 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690256 | afamitresgene autoleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690257 | carbidopa 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690258 | levodopa 140 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690260 | Crexont | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690261 | carbidopa 35 MG / levodopa 140 MG [Crexont] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690262 | Crexont Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690263 | Crexont Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690264 | carbidopa / levodopa Extended Release Oral Capsule [Crexont] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690266 | afamitresgene autoleucel 40000000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690267 | afamitresgene autoleucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690268 | afamitresgene autoleucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2690269 | afamitresgene autoleucel 10,000,000,000 CELLS in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690269 | afamitresgene autoleucel 10,000,000,000 CELLS in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690269 | afamitresgene autoleucel 10,000,000,000 CELLS in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690270 | afamitresgene autoleucel 40000000 CELLS/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2690270 | afamitresgene autoleucel 40000000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2690271 | Tecelra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690272 | afamitresgene autoleucel 40000000 CELLS/ML [Tecelra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690273 | Tecelra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690274 | afamitresgene autoleucel Injection [Tecelra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690275 | Tecelra 10,000,000,000 CELLS in 250 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690275 | Tecelra 10,000,000,000 CELLS in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690275 | Tecelra 10,000,000,000 CELLS in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690276 | Tecelra 40000000 CELLS/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2690276 | Tecelra 40000000 CELLS/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2690276 | Tecelra 40000000 CELLS/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690277 | carbidopa 52.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690278 | levodopa 210 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690280 | carbidopa 52.5 MG / levodopa 210 MG [Crexont] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690282 | carbidopa 70 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690283 | levodopa 280 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690285 | carbidopa 70 MG / levodopa 280 MG [Crexont] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690288 | carbidopa 87.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690289 | levodopa 350 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690291 | carbidopa 87.5 MG / levodopa 350 MG [Crexont] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690626 | benzgalantamine gluconate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2690627 | benzgalantamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690628 | benzgalantamine 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690629 | benzgalantamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690630 | benzgalantamine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690631 | benzgalantamine Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2690632 | benzgalantamine 5 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690632 | benzgalantamine 5 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690632 | benzgalantamine 5 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690633 | Zunveyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690634 | benzgalantamine 5 MG [Zunveyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690635 | Zunveyl Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690636 | Zunveyl Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690637 | benzgalantamine Delayed Release Oral Tablet [Zunveyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690638 | ZUNVEYL 5 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690638 | ZUNVEYL 5 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690638 | ZUNVEYL 5 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690639 | benzgalantamine 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690640 | benzgalantamine 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690640 | benzgalantamine 10 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690640 | benzgalantamine 10 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690641 | benzgalantamine 10 MG [Zunveyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690642 | ZUNVEYL 10 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690642 | ZUNVEYL 10 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690642 | ZUNVEYL 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690643 | benzgalantamine 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690644 | benzgalantamine 15 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690644 | benzgalantamine 15 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690644 | benzgalantamine 15 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690645 | benzgalantamine 15 MG [Zunveyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690646 | ZUNVEYL 15 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690646 | ZUNVEYL 15 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690646 | ZUNVEYL 15 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690647 | vorasidenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690648 | vorasidenib citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2690649 | vorasidenib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690650 | vorasidenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690651 | vorasidenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690652 | vorasidenib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2690653 | vorasidenib 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690653 | vorasidenib 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690653 | vorasidenib 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690654 | Voranigo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690655 | vorasidenib 10 MG [Voranigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690656 | Voranigo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690657 | Voranigo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690658 | vorasidenib Oral Tablet [Voranigo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690659 | Voranigo 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690659 | Voranigo 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690659 | Voranigo 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690660 | vorasidenib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690661 | vorasidenib 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690661 | vorasidenib 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690661 | vorasidenib 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690662 | vorasidenib 40 MG [Voranigo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690663 | Voranigo 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690663 | Voranigo 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690663 | Voranigo 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690725 | clonidine hydrochloride Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690726 | clonidine hydrochloride Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2690727 | cloNIDine hydrochloride 0.1 MG/mL 24HR Extended Release Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2690728 | clonidine hydrochloride 0.1 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2690728 | clonidine hydrochloride 0.1 MG/ML Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2690729 | Onyda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690730 | clonidine hydrochloride 0.1 MG/ML [Onyda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690730 | clonidine hydrochloride 0.1 MG/ML [Onyda] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690731 | Onyda Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690732 | Onyda Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690733 | clonidine Extended Release Suspension [Onyda] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690733 | clonidine Extended Release Suspension [Onyda] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690734 | clonidine hydrochloride Extended Release Suspension [Onyda] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690735 | ONYDA XR 0.1 MG/mL 24HR Extended Release Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690735 | ONYDA XR 0.1 MG/mL 24HR Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2690735 | ONYDA XR 0.1 MG/mL 24HR Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690735 | ONYDA XR 0.1 MG/mL 24HR Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690736 | clonidine hydrochloride 0.1 MG/ML Extended Release Suspension [Onyda] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2690736 | clonidine hydrochloride 0.1 MG/ML Extended Release Suspension [Onyda] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2690736 | clonidine hydrochloride 0.1 MG/ML Extended Release Suspension [Onyda] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690737 | Piper excelsum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690788 | Trachelospermum jasminoides stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690789 | angelicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690798 | Fenazepam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690798 | Fenazepam | Designated preferred name (PT) | NO | |
| RxCUI: 2690798 | Fenazepam | Full form of descriptor (FN) | NO | |
| RxCUI: 2690857 | tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2690857 | tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690857 | tovorafenib 400 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 16 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690858 | ojemda 400 MG Weekly Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2690858 | ojemda 400 MG Weekly Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690858 | ojemda 400 MG Weekly Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690859 | tovorafenib 500 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 20 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2690859 | tovorafenib 500 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 20 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690859 | tovorafenib 500 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 20 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690860 | ojemda 500 MG Weekly Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2690860 | ojemda 500 MG Weekly Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690860 | ojemda 500 MG Weekly Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690861 | tovorafenib 600 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 24 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2690861 | tovorafenib 600 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 24 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690861 | tovorafenib 600 MG Weekly Dose Carton Pack, 100 MG Oral Tablet 24 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690862 | ojemda 600 MG Weekly Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2690862 | ojemda 600 MG Weekly Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690862 | ojemda 600 MG Weekly Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690867 | N-carboxymethylchitosan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690868 | seladelpar lysine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2690869 | seladelpar | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2690870 | lidocaine HCl 4 % / menthol 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2690870 | lidocaine HCl 4 % / menthol 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690870 | lidocaine HCl 4 % / menthol 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2690871 | seladelpar 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690872 | seladelpar Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690873 | seladelpar Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2690874 | seladelpar Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2690875 | seladelpar 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690875 | seladelpar 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690875 | seladelpar 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690876 | Livdelzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690877 | seladelpar 10 MG [Livdelzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690878 | Livdelzi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690879 | Livdelzi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690880 | seladelpar Oral Capsule [Livdelzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2690881 | Livdelzi 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690881 | Livdelzi 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690881 | Livdelzi 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690882 | sulfur 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2690882 | sulfur 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690882 | sulfur 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2690883 | Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2690883 | Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2690883 | Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2690979 | Ocimum basilicum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690980 | Oldenlandia herbacea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690988 | triethanolamine lauroyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2690989 | maralixibat 19 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2690990 | maralixibat 19 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690990 | maralixibat 19 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690990 | maralixibat 19 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2690991 | maralixibat 19 MG/ML [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690992 | Livmarli 19 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2690992 | Livmarli 19 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2690992 | Livmarli 19 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2690995 | Tanlor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2690996 | methocarbamol 1000 MG [Tanlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2690997 | Tanlor Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690998 | Tanlor Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2690999 | methocarbamol Oral Tablet [Tanlor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 26910 | Hippurate hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 26910 | Hippurate hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 2691000 | Tanlor 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691000 | Tanlor 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691000 | Tanlor 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691003 | salicylic acid 0.057 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691004 | salicylic acid 5.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691004 | salicylic acid 5.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691004 | salicylic acid 5.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691005 | salicylic acid 0.063 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691006 | salicylic acid 6.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691006 | salicylic acid 6.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691006 | salicylic acid 6.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691092 | 1,3-cyclohexadiene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691093 | biotin 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2691094 | biotin / minoxidil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2691095 | biotin / minoxidil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2691096 | biotin / minoxidil Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2691097 | biotin 0.5 % / minoxidil 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691097 | biotin 0.5 % / minoxidil 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691097 | biotin 0.5 % / minoxidil 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691098 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691098 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691098 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691100 | lithium silicate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2691101 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691101 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691101 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691102 | diflunisal 375 MG [Dolobid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691103 | DOLOBID 375 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691103 | DOLOBID 375 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691103 | DOLOBID 375 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691104 | Ecklonia radiata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691105 | efetozole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691106 | ketoconazole Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2691107 | ketoconazole 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691107 | ketoconazole 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691107 | ketoconazole 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691113 | scopine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691147 | dexamethasone 0.00075 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2691147 | dexamethasone 0.00075 MG/MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2691148 | dexamethasone Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2691148 | dexamethasone Topical Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2691149 | dexAMETHasone 0.075 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691149 | dexAMETHasone 0.075 % Topical Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2691149 | dexAMETHasone 0.075 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691149 | dexAMETHasone 0.075 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691149 | dexAMETHasone 0.075 % Topical Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2691150 | lazertinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2691151 | lazertinib mesylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2691152 | lazertinib 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691153 | lazertinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2691154 | lazertinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2691155 | lazertinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2691156 | lazertinib 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691156 | lazertinib 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691156 | lazertinib 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691157 | Lazcluze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691158 | lazertinib 80 MG [Lazcluze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691159 | Lazcluze Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691160 | Lazcluze Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691161 | lazertinib Oral Tablet [Lazcluze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691162 | Lazcluze 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691162 | Lazcluze 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691162 | Lazcluze 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691162 | Lazcluze 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691163 | lazertinib 240 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691164 | lazertinib 240 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691164 | lazertinib 240 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691164 | lazertinib 240 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691165 | lazertinib 240 MG [Lazcluze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691166 | Lazcluze 240 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691166 | Lazcluze 240 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691166 | Lazcluze 240 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691166 | Lazcluze 240 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691168 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2691169 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691172 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.25 ML Prefilled Syringe, 6m through 11y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691172 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.25 ML Prefilled Syringe, 6m through 11y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691172 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.25 ML Prefilled Syringe, 6m through 11y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691173 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691175 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691175 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691175 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691176 | Spikevax 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691177 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML [Spikevax 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691178 | Spikevax 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691179 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Spikevax 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691181 | spikevax 2024-2025 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691181 | spikevax 2024-2025 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691181 | spikevax 2024-2025 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691182 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Spikevax 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691182 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Spikevax 2024-2025] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691185 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Injection, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691185 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Injection, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691185 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Injection, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691186 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691187 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injection [Spikevax 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2691189 | spikevax 2024-2025 vaccine, 0.5 ML Injection, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691189 | spikevax 2024-2025 vaccine, 0.5 ML Injection, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691189 | spikevax 2024-2025 vaccine, 0.5 ML Injection, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691190 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Injection [Spikevax 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691190 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Injection [Spikevax 2024-2025] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691192 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2691193 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691196 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691196 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691196 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691198 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691200 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 5y to < 12y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691200 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 5y to < 12y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691200 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 5y to < 12y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691201 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691203 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691205 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691205 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691205 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691206 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691207 | Comirnaty 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691208 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML [Comirnaty 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691209 | Comirnaty 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691210 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Comirnaty 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691212 | COMIRNATY 2024-2025 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691212 | COMIRNATY 2024-2025 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691212 | COMIRNATY 2024-2025 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691213 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Comirnaty 2024-2025] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691213 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Comirnaty 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691215 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691215 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691215 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.3 ML Injection, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691216 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691217 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injection [Comirnaty 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2691219 | COMIRNATY 2024-2025 vaccine, 0.3 ML Injection, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691219 | COMIRNATY 2024-2025 vaccine, 0.3 ML Injection, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691219 | COMIRNATY 2024-2025 vaccine, 0.3 ML Injection, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691220 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Injection [Comirnaty 2024-2025] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691220 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Injection [Comirnaty 2024-2025] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691285 | Emeprev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2691286 | maropitant 16 MG [Emeprev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2691287 | Emeprev Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2691288 | Emeprev Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2691289 | maropitant Oral Tablet [Emeprev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2691290 | Emeprev 16 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691290 | Emeprev 16 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691290 | Emeprev 16 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691291 | maropitant 160 MG [Emeprev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2691292 | Emeprev 160 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691292 | Emeprev 160 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691292 | Emeprev 160 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691293 | maropitant 24 MG [Emeprev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2691294 | Emeprev 24 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691294 | Emeprev 24 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691294 | Emeprev 24 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691295 | maropitant 60 MG [Emeprev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2691296 | Emeprev 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691296 | Emeprev 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691296 | Emeprev 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691297 | influenza A virus A/Thailand/8/2022 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691301 | influenza virus vaccine 2024-2025 Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691301 | influenza virus vaccine 2024-2025 Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691301 | influenza virus vaccine 2024-2025 Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691302 | FluMist 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691303 | influenza A virus A/Norway/31694/2022 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Thailand/8/2022 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML [FluMist 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691304 | FluMist 2024-2025 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691305 | FluMist 2024-2025 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691306 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691308 | FluMist 2024-2025 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691308 | FluMist 2024-2025 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691308 | FluMist 2024-2025 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691309 | nemolizumab-ilto | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2691310 | nemolizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2691311 | nemolizumab-ilto 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691312 | nemolizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2691317 | Nemluvio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691318 | nemolizumab-ilto 30 MG [Nemluvio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691319 | Nemluvio Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691323 | nemolizumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2691325 | nemolizumab-ilto 30 MG Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691325 | nemolizumab-ilto 30 MG Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691326 | nemolizumab Auto-Injector [Nemluvio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691328 | nemluvio 30 MG Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691328 | nemluvio 30 MG Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691328 | nemluvio 30 MG Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691333 | Ceftobiprole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2691333 | Ceftobiprole | Designated preferred name (PT) | YES | |
| RxCUI: 2691333 | Ceftobiprole | Full form of descriptor (FN) | YES | |
| RxCUI: 2691333 | Ceftobiprole | Designated preferred name (PT) | YES | |
| RxCUI: 2691333 | Ceftobiprole | Full form of descriptor (FN) | YES | |
| RxCUI: 2691334 | Ceftobiprole medocaril sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2691334 | Ceftobiprole medocaril sodium | Designated preferred name (PT) | YES | |
| RxCUI: 2691334 | Ceftobiprole medocaril sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 2691520 | 2-(1-methylbutyl)phenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691526 | axatilimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2691528 | axatilimab-csfr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2691529 | axatilimab-csfr 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2691530 | axatilimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2691531 | axatilimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2691534 | axatilimab-csfr 50 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691534 | axatilimab-csfr 50 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691534 | axatilimab-csfr 50 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691535 | axatilimab-csfr 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691536 | Niktimvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691537 | axatilimab-csfr 50 MG/ML [Niktimvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691538 | Niktimvo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691539 | axatilimab Injection [Niktimvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691541 | Niktimvo 50 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691541 | Niktimvo 50 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691541 | Niktimvo 50 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691541 | Niktimvo 50 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691542 | axatilimab-csfr 50 MG/ML Injection [Niktimvo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691542 | axatilimab-csfr 50 MG/ML Injection [Niktimvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691543 | tolnaftate / undecylenate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2691544 | tolnaftate / undecylenate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2691545 | tolnaftate / undecylenate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2691548 | tolnaftate 1 % / undecylenic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691548 | tolnaftate 1 % / undecylenic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691548 | tolnaftate 1 % / undecylenic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691549 | camphor 11 % / eucalyptus oil 10 % / menthol 8 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691549 | camphor 11 % / eucalyptus oil 10 % / menthol 8 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691549 | camphor 11 % / eucalyptus oil 10 % / menthol 8 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691685 | acetaminophen / diphenhydramine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2691685 | acetaminophen / diphenhydramine Chewable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691686 | acetaminophen / diphenhydramine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2691686 | acetaminophen / diphenhydramine Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691687 | acetaminophen / diphenhydramine hydrochloride Chewable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691688 | acetaminophen / diphenhydramine hydrochloride Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691689 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691689 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2691689 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691689 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691689 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2691820 | 8-pentadecanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691821 | polyquaternium-55 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691823 | thiafentanil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691824 | thiafentanil oxalate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2691826 | corn dextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2691830 | Agalsidase alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2691830 | Agalsidase alfa | Designated preferred name (PT) | NO | |
| RxCUI: 2691830 | Agalsidase alfa | Full form of descriptor (FN) | NO | |
| RxCUI: 2691830 | Agalsidase alfa | Designated preferred name (PT) | NO | |
| RxCUI: 2691830 | Agalsidase alfa | Full form of descriptor (FN) | NO | |
| RxCUI: 2691831 | camphor 3 % / menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691831 | camphor 3 % / menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691831 | camphor 3 % / menthol 3.5 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2691832 | Phyrago | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2691833 | dasatinib 100 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691834 | Phyrago Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691835 | Phyrago Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2691836 | dasatinib Oral Tablet [Phyrago] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2691837 | PHYRAGO 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691837 | PHYRAGO 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691837 | PHYRAGO 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691838 | dasatinib 140 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691839 | PHYRAGO 140 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691839 | PHYRAGO 140 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691839 | PHYRAGO 140 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691840 | dasatinib 20 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691841 | PHYRAGO 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691841 | PHYRAGO 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691841 | PHYRAGO 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691842 | dasatinib 50 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691843 | PHYRAGO 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691843 | PHYRAGO 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691843 | PHYRAGO 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691844 | dasatinib 70 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691845 | PHYRAGO 70 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691845 | PHYRAGO 70 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691845 | PHYRAGO 70 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691846 | dasatinib 80 MG [Phyrago] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2691847 | PHYRAGO 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2691847 | PHYRAGO 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2691847 | PHYRAGO 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2691848 | thiafentanil 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2691849 | thiafentanil Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2691850 | thiafentanil Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2691851 | thiafentanil 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691851 | thiafentanil 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2691852 | Thianil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2691853 | thiafentanil 10 MG/ML [Thianil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2691854 | Thianil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2691855 | thiafentanil Injectable Solution [Thianil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2691856 | Thianil 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2691856 | Thianil 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2691856 | Thianil 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692023 | 4-methyl-5-thiazoleethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2692049 | patiromer 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2692050 | patiromer 1 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692050 | patiromer 1 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692050 | patiromer 1 GM Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2692051 | patiromer 1000 MG [Veltassa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2692052 | Veltassa 1 GM Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2692052 | Veltassa 1 GM Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692052 | Veltassa 1 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692052 | Veltassa 1 GM Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692300 | acetaminophen / dextromethorphan / doxylamine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2692302 | acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2692302 | acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692302 | acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692302 | acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2692303 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2692304 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2692304 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2692304 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692304 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692304 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2692305 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2692306 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2692309 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 0.5 ML Prefilled Syringe, 12y+ (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2692309 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 0.5 ML Prefilled Syringe, 12y+ (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692309 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 0.5 ML Prefilled Syringe, 12y+ (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692310 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 Prefilled Syringe, 12y+ (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692310 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 Prefilled Syringe, 12y+ (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692310 | SARS-CoV-2 (COVID-19) vaccine 2024-2025, protein NVX-CoV2705 Prefilled Syringe, 12y+ (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26925 | histamine phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 26925 | histamine phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 26925 | histamine phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 2692682 | faricimab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2692684 | faricimab-svoa 6 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2692684 | faricimab-svoa 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692684 | faricimab-svoa 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692685 | faricimab-svoa 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2692686 | faricimab Prefilled Syringe [Vabysmo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2692688 | Vabysmo 6 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2692688 | Vabysmo 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692688 | Vabysmo 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692688 | Vabysmo 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2692689 | faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692689 | faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692739 | docusate sodium 250 MG [Colace] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692740 | Colace 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692740 | Colace 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692740 | Colace 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692740 | Colace 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26928 | Histidine aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26928 | Histidine aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2692871 | sodium sulfide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2692878 | traMADol hydrochloride 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2692878 | traMADol hydrochloride 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2692878 | traMADol hydrochloride 75 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2692879 | Betacilin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2692880 | amoxicillin 100 MG / clavulanate 25 MG [Betacilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692881 | Betacilin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2692882 | Betacilin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2692883 | amoxicillin / clavulanate Oral Tablet [Betacilin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2692884 | Betacilin 100 MG / 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692884 | Betacilin 100 MG / 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692884 | Betacilin 100 MG / 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692885 | amoxicillin 200 MG / clavulanate 50 MG [Betacilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692886 | Betacilin 200 MG / 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692886 | Betacilin 200 MG / 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692886 | Betacilin 200 MG / 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692887 | amoxicillin 300 MG / clavulanate 75 MG [Betacilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692888 | Betacilin 300 MG / 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692888 | Betacilin 300 MG / 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692888 | Betacilin 300 MG / 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692889 | amoxicillin 50 MG / clavulanate 12.5 MG [Betacilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692890 | Betacilin 50 MG / 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692890 | Betacilin 50 MG / 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692890 | Betacilin 50 MG / 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692891 | amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Betacilin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692892 | Betacilin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2692893 | amoxicillin / clavulanate Oral Suspension [Betacilin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2692894 | Betacilin 250 MG / 62.5 MG per 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692894 | Betacilin 250 MG / 62.5 MG per 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2692894 | Betacilin 250 MG / 62.5 MG per 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692960 | Tzed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2692961 | tiletamine 50 MG/ML / zolazepam 50 MG/ML [Tzed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2692962 | Tzed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2692963 | tiletamine / zolazepam Injectable Solution [Tzed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2692964 | Tzed 50 MG/ML / 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2692964 | Tzed 50 MG/ML / 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2692964 | Tzed 50 MG/ML / 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693086 | guselkumab 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693087 | guselkumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693088 | guselkumab 200 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693088 | guselkumab 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693088 | guselkumab 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693089 | guselkumab 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693089 | guselkumab 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693090 | guselkumab 10 MG/ML [Tremfya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693091 | guselkumab Injection [Tremfya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693092 | Tremfya 200 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693092 | Tremfya 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693092 | Tremfya 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693093 | Tremfya 10 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693093 | Tremfya 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693093 | Tremfya 10 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693094 | guselkumab 200 MG in 2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693094 | guselkumab 200 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693094 | guselkumab 200 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693095 | Tremfya 200 MG in 2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693095 | Tremfya 200 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693095 | Tremfya 200 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693096 | guselkumab 200 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693096 | guselkumab 200 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693096 | guselkumab 200 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693097 | Tremfya 200 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693097 | Tremfya 200 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693097 | Tremfya 200 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693182 | letermovir 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693183 | letermovir Pellet Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2693184 | letermovir Oral Pellet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693185 | letermovir 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693185 | letermovir 20 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693186 | letermovir 20 MG [Prevymis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693187 | Prevymis Pellet Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693188 | letermovir Oral Pellet [Prevymis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693189 | PREVYMIS 20 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693189 | PREVYMIS 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693189 | PREVYMIS 20 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693190 | letermovir 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693191 | letermovir 120 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693191 | letermovir 120 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693192 | letermovir 120 MG [Prevymis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693193 | PREVYMIS 120 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693193 | PREVYMIS 120 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693193 | PREVYMIS 120 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693194 | oxyCODONE hydrochloride 10 MG Oral Tablet, Abuse-Deterrent | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693194 | oxyCODONE hydrochloride 10 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693194 | oxyCODONE hydrochloride 10 MG Oral Tablet, Abuse-Deterrent | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693194 | oxyCODONE hydrochloride 10 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693194 | oxyCODONE hydrochloride 10 MG Oral Tablet, Abuse-Deterrent | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693195 | oxycodone hydrochloride 10 MG [Roxybond] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693195 | oxycodone hydrochloride 10 MG [Roxybond] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693196 | RoxyBond 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693196 | RoxyBond 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693196 | RoxyBond 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693196 | RoxyBond 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693246 | Undecatrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693247 | testosterone undecanoate 200 MG [Undecatrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693248 | Undecatrex Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693249 | Undecatrex Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693250 | testosterone Oral Capsule [Undecatrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693252 | Undecatrex 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693252 | Undecatrex 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693252 | Undecatrex 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693253 | potassium chloride 15 MEQ (1125 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693253 | potassium chloride 15 MEQ (1125 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693253 | potassium chloride 15 MEQ (1125 MG) Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693253 | potassium chloride 15 MEQ (1125 MG) Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693253 | potassium chloride 15 MEQ (1125 MG) Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693283 | 2,3-pentanedione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2693284 | benzoin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693285 | citronellic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693286 | decanoic acid, 1-methylbutyl ester | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693414 | ilunocitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2693415 | ilunocitinib 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2693416 | ilunocitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2693417 | ilunocitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2693418 | ilunocitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2693419 | ilunocitinib 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693419 | ilunocitinib 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693420 | Zenrelia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2693421 | ilunocitinib 15 MG [Zenrelia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2693422 | Zenrelia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2693423 | Zenrelia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2693424 | ilunocitinib Oral Tablet [Zenrelia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2693425 | Zenrelia 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693425 | Zenrelia 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693425 | Zenrelia 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693426 | ilunocitinib 4.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2693427 | ilunocitinib 4.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693427 | ilunocitinib 4.8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693428 | ilunocitinib 4.8 MG [Zenrelia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2693429 | Zenrelia 4.8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693429 | Zenrelia 4.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693429 | Zenrelia 4.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693430 | ilunocitinib 6.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2693431 | ilunocitinib 6.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693431 | ilunocitinib 6.4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693432 | ilunocitinib 6.4 MG [Zenrelia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2693433 | Zenrelia 6.4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693433 | Zenrelia 6.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693433 | Zenrelia 6.4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693434 | ilunocitinib 8.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2693435 | ilunocitinib 8.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693435 | ilunocitinib 8.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693436 | ilunocitinib 8.5 MG [Zenrelia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2693437 | Zenrelia 8.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693437 | Zenrelia 8.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693437 | Zenrelia 8.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693441 | epinephrine Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693441 | epinephrine Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693442 | EPINEPHrine 2 MG in 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693442 | EPINEPHrine 2 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693442 | EPINEPHrine 2 MG in 0.1 ML Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693442 | EPINEPHrine 2 MG in 0.1 ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693442 | EPINEPHrine 2 MG in 0.1 ML Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693443 | Neffy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693444 | epinephrine 20 MG/ML [Neffy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693444 | epinephrine 20 MG/ML [Neffy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693445 | Neffy Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693446 | Neffy Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693447 | epinephrine Nasal Spray [Neffy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693447 | epinephrine Nasal Spray [Neffy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693448 | neffy 2 MG in 0.1 ML Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693448 | neffy 2 MG in 0.1 ML Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2693448 | neffy 2 MG in 0.1 ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693448 | neffy 2 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693448 | neffy 2 MG in 0.1 ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693449 | ocrelizumab-ocsq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693450 | ocrelizumab-ocsq 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693451 | hyaluronidase-ocsq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693452 | hyaluronidase-ocsq 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693453 | (ocrelizumab / hyaluronidase)-ocsq | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693453 | (ocrelizumab / hyaluronidase)-ocsq | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2693454 | hyaluronidase / ocrelizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2693455 | hyaluronidase / ocrelizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693458 | ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693458 | ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693458 | ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693458 | ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693459 | hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693460 | Ocrevus Zunovo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693461 | hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML [Ocrevus Zunovo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693462 | Ocrevus Zunovo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693463 | hyaluronidase / ocrelizumab Injection [Ocrevus Zunovo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693465 | Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693465 | Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693465 | Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693466 | hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693563 | aflibercept Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693564 | aflibercept 2 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693564 | aflibercept 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693564 | aflibercept 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693565 | aflibercept 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693566 | aflibercept Prefilled Syringe [Eylea] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693567 | EYLEA 2 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693567 | EYLEA 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693567 | EYLEA 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693567 | EYLEA 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693568 | aflibercept 40 MG/ML Prefilled Syringe [Eylea] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693568 | aflibercept 40 MG/ML Prefilled Syringe [Eylea] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693617 | levacetylleucine 1 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693617 | levacetylleucine 1 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693617 | levacetylleucine 1 GM Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693618 | Aqneursa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693620 | Aqneursa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693621 | Aqneursa Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693623 | AQNEURSA 1 GM Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693623 | AQNEURSA 1 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693623 | AQNEURSA 1 GM Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693623 | AQNEURSA 1 GM Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693624 | copper sulfate 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693625 | manganese sulfate 0.151 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693626 | zinc sulfate 7.41 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693627 | copper sulfate 0.75 MG (copper 0.3 MG) / manganese sulfate 151 MCG (manganese 55 MCG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 7.41 MG (zinc 3 MG) in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693627 | copper sulfate 0.75 MG (copper 0.3 MG) / manganese sulfate 151 MCG (manganese 55 MCG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 7.41 MG (zinc 3 MG) in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693627 | copper sulfate 0.75 MG (copper 0.3 MG) / manganese sulfate 151 MCG (manganese 55 MCG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 7.41 MG (zinc 3 MG) in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693627 | copper sulfate 0.75 MG (copper 0.3 MG) / manganese sulfate 151 MCG (manganese 55 MCG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 7.41 MG (zinc 3 MG) in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693628 | copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / ZnSO4 7.41 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693628 | copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / ZnSO4 7.41 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693629 | Tralement | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693630 | copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 7.41 MG/ML [Tralement] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693631 | Tralement Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693632 | copper sulfate / manganese sulfate / selenious acid / zinc sulfate Injection [Tralement] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693633 | Tralement trace elements 4 in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693633 | Tralement trace elements 4 in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693633 | Tralement trace elements 4 in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693633 | Tralement trace elements 4 in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693634 | copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 7.41 MG/ML Injection [Tralement] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693634 | copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 7.41 MG/ML Injection [Tralement] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693635 | palopegteriparatide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693636 | teriparatide 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693637 | palopegteriparatide 168 MCG in 0.56 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693637 | palopegteriparatide 168 MCG in 0.56 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693637 | palopegteriparatide 168 MCG in 0.56 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693638 | teriparatide 0.3 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693639 | Yorvipath | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693640 | teriparatide 0.3 MG/ML [Yorvipath] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693641 | Yorvipath Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693642 | teriparatide Pen Injector [Yorvipath] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693643 | Yorvipath 168 MCG in 0.56 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693643 | Yorvipath 168 MCG in 0.56 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693643 | Yorvipath 168 MCG in 0.56 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693643 | Yorvipath 168 MCG in 0.56 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693644 | teriparatide 0.3 MG/ML Pen Injector [Yorvipath] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693644 | teriparatide 0.3 MG/ML Pen Injector [Yorvipath] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693645 | palopegteriparatide 294 MCG in 0.98 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693645 | palopegteriparatide 294 MCG in 0.98 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693645 | palopegteriparatide 294 MCG in 0.98 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693646 | Yorvipath 294 MCG in 0.98 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693646 | Yorvipath 294 MCG in 0.98 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693646 | Yorvipath 294 MCG in 0.98 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693646 | Yorvipath 294 MCG in 0.98 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693647 | palopegteriparatide 420 MCG in 1.4 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693647 | palopegteriparatide 420 MCG in 1.4 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693647 | palopegteriparatide 420 MCG in 1.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693648 | Yorvipath 420 MCG in 1.4 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693648 | Yorvipath 420 MCG in 1.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693648 | Yorvipath 420 MCG in 1.4 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693648 | Yorvipath 420 MCG in 1.4 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 26937 | Histidinol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 26937 | Histidinol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 2693758 | lebrikizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2693758 | lebrikizumab | Designated preferred name (PT) | YES | |
| RxCUI: 2693758 | lebrikizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 2693770 | acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693770 | acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693770 | acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693770 | acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693771 | miconazole 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693771 | miconazole 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693771 | miconazole 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693772 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693772 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693772 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693772 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693772 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693773 | acetaminophen / diphenhydramine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2693773 | acetaminophen / diphenhydramine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693774 | acetaminophen / diphenhydramine hydrochloride Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693775 | acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693776 | 1 daytime (acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2693776 | 1 daytime (acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693776 | 1 daytime (acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693776 | 1 daytime (acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693776 | 1 daytime (acetaminophen 320 MG / dextromethorphan HBr 5 MG in 10 mL Oral Suspension) / 1 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG in 10 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2693777 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2693777 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693777 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG in 20 mL Oral Suspension) / 1 nighttime (acetaminophen 650 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 20 mL Oral Suspension) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693778 | lebrikizumab-lbkz | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693779 | lebrikizumab-lbkz 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693780 | lebrikizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2693781 | lebrikizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693784 | lebrikizumab-lbkz 250 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693784 | lebrikizumab-lbkz 250 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693784 | lebrikizumab-lbkz 250 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693785 | lebrikizumab-lbkz 125 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693786 | Ebglyss | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693787 | lebrikizumab-lbkz 125 MG/ML [Ebglyss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693788 | Ebglyss Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693789 | lebrikizumab Prefilled Syringe [Ebglyss] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693791 | Ebglyss 250 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693791 | Ebglyss 250 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693791 | Ebglyss 250 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693791 | Ebglyss 250 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693792 | lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693792 | lebrikizumab-lbkz 125 MG/ML Prefilled Syringe [Ebglyss] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 26938 | Imidazolylacetolphosphate aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26938 | Imidazolylacetolphosphate aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 26938 | Imidazolylacetolphosphate aminotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693883 | atezolizumab-tqjs | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693884 | atezolizumab-tqjs 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693885 | hyaluronidase-tqjs | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2693886 | hyaluronidase-tqjs 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2693887 | (atezolizumab / hyaluronidase)-tqjs | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693887 | (atezolizumab / hyaluronidase)-tqjs | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2693888 | atezolizumab / hyaluronidase Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2693889 | atezolizumab / hyaluronidase Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693892 | atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT in 15 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693892 | atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693892 | atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693893 | atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693894 | Tecentriq Hybreza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693895 | atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML [Tecentriq Hybreza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693896 | Tecentriq Hybreza Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693897 | atezolizumab / hyaluronidase Injection [Tecentriq Hybreza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693899 | Tecentriq Hybreza 1875 MG / 30,000 UNT in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693899 | Tecentriq Hybreza 1875 MG / 30,000 UNT in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693899 | Tecentriq Hybreza 1875 MG / 30,000 UNT in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693900 | atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection [Tecentriq Hybreza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693901 | lebrikizumab Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2693903 | lebrikizumab-lbkz 250 MG in 2 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2693903 | lebrikizumab-lbkz 250 MG in 2 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693903 | lebrikizumab-lbkz 250 MG in 2 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693904 | lebrikizumab-lbkz 125 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2693905 | lebrikizumab Pen Injector [Ebglyss] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693907 | Ebglyss 250 MG in 2 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693907 | Ebglyss 250 MG in 2 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693907 | Ebglyss 250 MG in 2 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693907 | Ebglyss 250 MG in 2 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693908 | lebrikizumab-lbkz 125 MG/ML Pen Injector [Ebglyss] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693908 | lebrikizumab-lbkz 125 MG/ML Pen Injector [Ebglyss] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693986 | Acorus gramineus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2693987 | bruceantin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2693988 | javanicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2693992 | Boruzu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2693993 | bortezomib 2.5 MG/ML [Boruzu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2693994 | Boruzu Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2693995 | bortezomib Injection [Boruzu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2693996 | BORUZU 3.5 MG in 1.4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2693996 | BORUZU 3.5 MG in 1.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693996 | BORUZU 3.5 MG in 1.4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2693996 | BORUZU 3.5 MG in 1.4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2693997 | bortezomib 2.5 MG/ML Injection [Boruzu] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2693997 | bortezomib 2.5 MG/ML Injection [Boruzu] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693998 | acetylcysteine 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2693999 | acetylcysteine 2.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2693999 | acetylcysteine 2.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2693999 | acetylcysteine 2.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2694002 | methylphenidate hydrochloride 40 MG [QuilliChew] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694005 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2694006 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen 0.015 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694007 | influenza A virus (H5N1) antigen Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2694010 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694010 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694010 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694011 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen 0.015 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2694012 | Audenz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2694013 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen 0.015 MG/ML [Audenz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694014 | Audenz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694015 | influenza A virus (H5N1) antigen Prefilled Syringe [Audenz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694017 | AUDENZ vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694017 | AUDENZ vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694017 | AUDENZ vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694017 | AUDENZ vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694018 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen 0.015 MG/ML Prefilled Syringe [Audenz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694018 | influenza A virus A/turkey/Turkey/1/2005 (H5N1) antigen 0.015 MG/ML Prefilled Syringe [Audenz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2694020 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694020 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694020 | influenza A (H5N1) virus vaccine (monovalent - turkey/Turkey/1/2005) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694021 | influenza A virus (H5N1) antigen Injectable Suspension [Audenz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694023 | AUDENZ vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694023 | AUDENZ vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694023 | AUDENZ vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694023 | AUDENZ vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694076 | PEG-PPG-4-30 copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2694077 | phenyl-n-tert-butylnitrone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2694114 | succinylcholine chloride 200 MG in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694114 | succinylcholine chloride 200 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694114 | succinylcholine chloride 200 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694115 | undecylenic acid 0.08 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2694116 | undecylenate Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2694118 | undecylenic acid 8 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2694118 | undecylenic acid 8 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694118 | undecylenic acid 8 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694282 | arimoclomol citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2694283 | arimoclomol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2694284 | arimoclomol 124 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694285 | arimoclomol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2694286 | arimoclomol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2694287 | arimoclomol Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2694288 | arimoclomol 124 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694288 | arimoclomol 124 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694288 | arimoclomol 124 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694289 | Miplyffa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2694290 | arimoclomol 124 MG [Miplyffa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694291 | Miplyffa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694292 | Miplyffa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694293 | arimoclomol Oral Capsule [Miplyffa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694294 | MIPLYFFA 124 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694294 | MIPLYFFA 124 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694294 | MIPLYFFA 124 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694295 | arimoclomol 47 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694296 | arimoclomol 47 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694296 | arimoclomol 47 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694296 | arimoclomol 47 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694297 | arimoclomol 47 MG [Miplyffa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694298 | MIPLYFFA 47 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694298 | MIPLYFFA 47 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694298 | MIPLYFFA 47 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694299 | arimoclomol 62 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694300 | arimoclomol 62 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694300 | arimoclomol 62 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694300 | arimoclomol 62 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694301 | arimoclomol 62 MG [Miplyffa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694302 | MIPLYFFA 62 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694302 | MIPLYFFA 62 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694302 | MIPLYFFA 62 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694303 | arimoclomol 93 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694304 | arimoclomol 93 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694304 | arimoclomol 93 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694304 | arimoclomol 93 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694305 | arimoclomol 93 MG [Miplyffa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694306 | MIPLYFFA 93 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694306 | MIPLYFFA 93 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694306 | MIPLYFFA 93 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694307 | testosterone Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2694309 | testosterone cypionate 200 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694309 | testosterone cypionate 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694309 | testosterone cypionate 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694310 | testosterone cypionate 200 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694310 | testosterone cypionate 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2694311 | Azmiro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2694312 | testosterone cypionate 200 MG/ML [Azmiro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694313 | Azmiro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694314 | testosterone Prefilled Syringe [Azmiro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694316 | AZMIRO 200 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694316 | AZMIRO 200 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694316 | AZMIRO 200 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694317 | AZMIRO 200 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694317 | AZMIRO 200 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694317 | AZMIRO 200 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2694318 | testosterone Injection [Azmiro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694320 | AZMIRO 200 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694320 | AZMIRO 200 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694320 | AZMIRO 200 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694321 | AZMIRO 200 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694321 | AZMIRO 200 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694321 | AZMIRO 200 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2694728 | benzaldehyde propylene glycol acetal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2694729 | camphor 3.1 % / capsaicin 0.025 % / menthol 6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2694729 | camphor 3.1 % / capsaicin 0.025 % / menthol 6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694729 | camphor 3.1 % / capsaicin 0.025 % / menthol 6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694828 | xanomeline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2694829 | xanomeline tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2694830 | Moxisolv | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2694831 | moxidectin 10 MG/ML [Moxisolv] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2694832 | Moxisolv Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2694833 | moxidectin Injectable Solution [Moxisolv] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2694834 | MoxiSolv 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2694834 | MoxiSolv 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2694834 | MoxiSolv 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2694835 | xanomeline 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694836 | trospium / xanomeline | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2694837 | trospium / xanomeline Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2694838 | trospium / xanomeline Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2694839 | trospium / xanomeline Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2694843 | xanomeline 50 MG / trospium chloride 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694843 | xanomeline 50 MG / trospium chloride 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694843 | xanomeline 50 MG / trospium chloride 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694844 | Cobenfy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2694845 | trospium chloride 20 MG / xanomeline 50 MG [Cobenfy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694846 | Cobenfy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694847 | Cobenfy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2694848 | trospium / xanomeline Oral Capsule [Cobenfy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2694850 | COBENFY 50 MG / 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694850 | COBENFY 50 MG / 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694850 | COBENFY 50 MG / 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694850 | COBENFY 50 MG / 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694851 | trospium chloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694852 | xanomeline 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694853 | xanomeline 125 MG / trospium chloride 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694853 | xanomeline 125 MG / trospium chloride 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694853 | xanomeline 125 MG / trospium chloride 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694854 | trospium chloride 30 MG / xanomeline 125 MG [Cobenfy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694855 | COBENFY 125 MG / 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694855 | COBENFY 125 MG / 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694855 | COBENFY 125 MG / 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694855 | COBENFY 125 MG / 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 26949 | histolyn CYL | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2694988 | xanomeline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2694989 | xanomeline 100 MG / trospium chloride 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2694989 | xanomeline 100 MG / trospium chloride 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694989 | xanomeline 100 MG / trospium chloride 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694990 | trospium chloride 20 MG / xanomeline 100 MG [Cobenfy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2694991 | COBENFY 100 MG / 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694991 | COBENFY 100 MG / 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694991 | COBENFY 100 MG / 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694991 | COBENFY 100 MG / 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2694992 | xanomeline/trospium chloride 28-Day Starter Kit 56 Count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2694992 | xanomeline/trospium chloride 28-Day Starter Kit 56 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694992 | xanomeline/trospium chloride 28-Day Starter Kit 56 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2694993 | COBENFY 28-Day Starter Kit 56 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2694993 | COBENFY 28-Day Starter Kit 56 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2694993 | COBENFY 28-Day Starter Kit 56 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695027 | Euphorbia sieboldiana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695028 | epinephrine 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695028 | epinephrine 0.016 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695029 | EPINEPHrine 4 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695029 | EPINEPHrine 4 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695029 | EPINEPHrine 4 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695029 | EPINEPHrine 4 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695029 | EPINEPHrine 4 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695030 | epinephrine 0.016 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2695030 | epinephrine 0.016 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2695031 | epinephrine 0.016 MG/ML [Adrenalin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695031 | epinephrine 0.016 MG/ML [Adrenalin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695032 | Adrenalin 4 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695032 | Adrenalin 4 MG in 250 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695032 | Adrenalin 4 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695032 | Adrenalin 4 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695032 | Adrenalin 4 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695033 | epinephrine 0.016 MG/ML Injection [Adrenalin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2695033 | epinephrine 0.016 MG/ML Injection [Adrenalin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2695033 | epinephrine 0.016 MG/ML Injection [Adrenalin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2695046 | pyridostigmine bromide 105 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695046 | pyridostigmine bromide 105 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695047 | pyRIDostigmine bromide 105 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695048 | pyridostigmine bromide 105 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2695048 | pyridostigmine bromide 105 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 26951 | Histone acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26951 | Histone acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2695380 | behenyl arachidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695381 | ceteareth-27 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695417 | Aconitum carmichaeli whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695422 | inavolisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2695423 | inavolisib 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695424 | inavolisib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2695425 | inavolisib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2695426 | inavolisib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2695427 | inavolisib 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695427 | inavolisib 3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695428 | Itovebi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2695429 | inavolisib 3 MG [Itovebi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695430 | Itovebi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2695431 | Itovebi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2695432 | inavolisib Oral Tablet [Itovebi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2695433 | Itovebi 3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695433 | Itovebi 3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695433 | Itovebi 3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695434 | inavolisib 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695435 | inavolisib 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695435 | inavolisib 9 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695436 | inavolisib 9 MG [Itovebi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695437 | Itovebi 9 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695437 | Itovebi 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695437 | Itovebi 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695438 | pilocarpine hydrochloride 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695439 | pilocarpine hydrochloride 0.4 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695439 | pilocarpine hydrochloride 0.4 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695439 | pilocarpine hydrochloride 0.4 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695440 | Qlosi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2695441 | pilocarpine hydrochloride 4 MG/ML [Qlosi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695442 | Qlosi Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2695443 | pilocarpine Ophthalmic Solution [Qlosi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2695445 | Qlosi 0.4 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695445 | Qlosi 0.4 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695445 | Qlosi 0.4 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695445 | Qlosi 0.4 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695446 | Comfortlax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2695447 | polyethylene glycol 3350 17000 MG [Comfortlax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2695448 | Comfortlax Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2695449 | Comfortlax Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2695450 | polyethylene glycol 3350 Powder for Oral Solution [Comfortlax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2695451 | COMFORTLAX 17 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2695451 | COMFORTLAX 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2695451 | COMFORTLAX 17 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2695451 | COMFORTLAX 17 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2695452 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 in 30 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG in 30 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2695452 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 in 30 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG in 30 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695452 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 in 30 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG in 30 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695452 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 in 30 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG in 30 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695452 | 1 daytime (acetaminophen 650 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 in 30 mL Oral Solution) / 1 nighttime (acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG in 30 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2695669 | methyl salicylate 0.55 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2695670 | camphor 11 % / menthol 9 % / methyl salicylate 55 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2695670 | camphor 11 % / menthol 9 % / methyl salicylate 55 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2695670 | camphor 11 % / menthol 9 % / methyl salicylate 55 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2695671 | xanomeline/trospium chloride 7-Day Titration Pack - 50 MG/20 MG (4), 100 MG/20 MG (10) 14 Count | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2695671 | xanomeline/trospium chloride 7-Day Titration Pack - 50 MG/20 MG (4), 100 MG/20 MG (10) 14 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695671 | xanomeline/trospium chloride 7-Day Titration Pack - 50 MG/20 MG (4), 100 MG/20 MG (10) 14 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695672 | COBENFY 7-Day Titration Pack 14 Count | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2695672 | COBENFY 7-Day Titration Pack 14 Count | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695672 | COBENFY 7-Day Titration Pack 14 Count | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695722 | Curcuma longa root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695722 | Curcuma longa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2695771 | sodium monofluorophosphate 0.0079 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2695772 | sodium monofluorophosphate 0.79 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2695772 | sodium monofluorophosphate 0.79 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2695772 | sodium monofluorophosphate 0.79 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2695774 | Foscarbidopa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2695774 | Foscarbidopa | Designated preferred name (PT) | YES | |
| RxCUI: 2695774 | Foscarbidopa | Full form of descriptor (FN) | YES | |
| RxCUI: 2695775 | Foslevodopa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2695775 | Foslevodopa | Designated preferred name (PT) | YES | |
| RxCUI: 2695775 | Foslevodopa | Full form of descriptor (FN) | YES | |
| RxCUI: 2695775 | Foslevodopa | Designated preferred name (PT) | YES | |
| RxCUI: 2695775 | Foslevodopa | Full form of descriptor (FN) | YES | |
| RxCUI: 2695776 | foscarbidopa 12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695777 | foslevodopa 240 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695778 | carbidopa / levodopa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2695779 | carbidopa / levodopa Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2695782 | foscarbidopa 120 MG / foslevodopa 2400 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695782 | foscarbidopa 120 MG / foslevodopa 2400 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695782 | foscarbidopa 120 MG / foslevodopa 2400 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695783 | foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2695784 | Vyalev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2695785 | foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML [Vyalev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695786 | Vyalev Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2695787 | carbidopa / levodopa Injection [Vyalev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2695789 | VYALEV 120 MG / 2400 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695789 | VYALEV 120 MG / 2400 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695789 | VYALEV 120 MG / 2400 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695790 | foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection [Vyalev] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2695791 | Coffea arabica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2695867 | Allium cepa bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2695869 | zolbetuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2695870 | zolbetuximab-clzb | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2695871 | zolbetuximab-clzb 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2695872 | zolbetuximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2695873 | zolbetuximab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2695876 | zolbetuximab-clzb 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695876 | zolbetuximab-clzb 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2695877 | Vyloy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2695878 | zolbetuximab-clzb 100 MG [Vyloy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2695879 | Vyloy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2695880 | zolbetuximab Injection [Vyloy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2695882 | VYLOY 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2695882 | VYLOY 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2695882 | VYLOY 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2695984 | Cyperus prolifer whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695988 | 1-dodecylperhydroazepine-1-oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2695992 | acrylate/butylaminoethyl methacrylate/methyl acrylate/methyl methacrylate/octylacrylamide copolymer (40000 WAMW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2696072 | camphor 4 % / menthol 4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2696072 | camphor 4 % / menthol 4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2696072 | camphor 4 % / menthol 4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2696074 | Xromi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2696075 | hydroxyurea 100 MG/ML [Xromi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696076 | Xromi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2696077 | Xromi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2696078 | hydroxyurea Oral Solution [Xromi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2696079 | Xromi 100 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696079 | Xromi 100 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696079 | Xromi 100 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696125 | Potassium bicarbonate 2.5 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2696125 | Potassium bicarbonate 2.5 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2696127 | Lansoprazole 30 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696127 | Lansoprazole 30 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696129 | Lansoprazole 15 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696129 | Lansoprazole 15 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696131 | Didanosine 125 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696131 | Didanosine 125 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696133 | Budesonide 3 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696133 | Budesonide 3 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696135 | Oxaprozin 600 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696135 | Oxaprozin 600 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696137 | Omeprazole 40 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696137 | Omeprazole 40 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696139 | Didanosine 250 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696139 | Didanosine 250 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696141 | Didanosine 200 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696141 | Didanosine 200 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696143 | Monomethyl fumarate 95 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696143 | Monomethyl fumarate 95 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696145 | Omeprazole 20 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696145 | Omeprazole 20 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696147 | Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2696147 | Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2696149 | Pantoprazole sodium 40 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2696149 | Pantoprazole sodium 40 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2696151 | Diclofenac sodium 50 mg and misoprostol 200 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2696151 | Diclofenac sodium 50 mg and misoprostol 200 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2696153 | Budesonide 200 microgram/actuation solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2696153 | Budesonide 200 microgram/actuation solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2696154 | Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696154 | Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696155 | Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696155 | Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696158 | Prochlorperazine 15 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696158 | Prochlorperazine 15 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696160 | Hyoscyamine sulfate 375 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696160 | Hyoscyamine sulfate 375 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696162 | Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696162 | Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696164 | Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696164 | Product containing precisely theophylline anhydrous 400 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696166 | Prochlorperazine 10 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696166 | Prochlorperazine 10 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696168 | Nitroglycerin 2.5 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2696168 | Nitroglycerin 2.5 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2696249 | Gallifrey | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2696250 | norethindrone acetate 5 MG [Gallifrey] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696251 | Gallifrey Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2696252 | Gallifrey Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2696253 | norethindrone Oral Tablet [Gallifrey] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2696255 | Gallifrey 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696255 | Gallifrey 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696255 | Gallifrey 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696256 | aflibercept-ayyh | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2696257 | aflibercept-ayyh 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2696260 | aflibercept-ayyh 2 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696260 | aflibercept-ayyh 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696260 | aflibercept-ayyh 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696261 | aflibercept-ayyh 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2696262 | Pavblu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2696263 | aflibercept-ayyh 40 MG/ML [Pavblu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696264 | Pavblu Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2696265 | aflibercept Prefilled Syringe [Pavblu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2696267 | PAVBLU 2 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696267 | PAVBLU 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696267 | PAVBLU 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696267 | PAVBLU 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696268 | aflibercept-ayyh 40 MG/ML Prefilled Syringe [Pavblu] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2696268 | aflibercept-ayyh 40 MG/ML Prefilled Syringe [Pavblu] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2696270 | aflibercept-ayyh 2 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696270 | aflibercept-ayyh 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696270 | aflibercept-ayyh 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696271 | aflibercept-ayyh 40 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2696272 | aflibercept Injection [Pavblu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2696274 | PAVBLU 2 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696274 | PAVBLU 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696274 | PAVBLU 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696274 | PAVBLU 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696275 | aflibercept-ayyh 40 MG/ML Injection [Pavblu] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2696275 | aflibercept-ayyh 40 MG/ML Injection [Pavblu] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2696276 | coagulation factor VIIa (recombinant)-jncw 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2696277 | coagulation factor VIIa (recombinant)-jncw 2 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696277 | coagulation factor VIIa (recombinant)-jncw 2 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696278 | coagulation factor VIIa (recombinant)-jncw 2 MG [Sevenfact] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696279 | SevenFACT 2 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696279 | SevenFACT 2 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696279 | SevenFACT 2 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696280 | metformin / sitagliptin Extended Release Oral Tablet [Zituvimet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2696280 | metformin / sitagliptin Extended Release Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696281 | metformin hydrochloride / sitagliptin Extended Release Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696282 | Zituvimet XR 50 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696282 | Zituvimet XR 50 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696282 | Zituvimet XR 50 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696282 | Zituvimet XR 50 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696283 | metformin hydrochloride 1000 MG / sitagliptin 50 MG Extended Release Oral Tablet [Zituvimet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2696283 | metformin hydrochloride 1000 MG / sitagliptin 50 MG Extended Release Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2696284 | Zituvimet XR 50 MG / 500 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696284 | Zituvimet XR 50 MG / 500 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696284 | Zituvimet XR 50 MG / 500 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696284 | Zituvimet XR 50 MG / 500 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696285 | metformin hydrochloride 500 MG / sitagliptin 50 MG Extended Release Oral Tablet [Zituvimet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2696285 | metformin hydrochloride 500 MG / sitagliptin 50 MG Extended Release Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2696286 | metformin hydrochloride 1000 MG / sitagliptin 100 MG [Zituvimet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696286 | metformin hydrochloride 1000 MG / sitagliptin 100 MG [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696287 | Zituvimet XR 100 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696287 | Zituvimet XR 100 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2696287 | Zituvimet XR 100 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696287 | Zituvimet XR 100 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696288 | metformin hydrochloride 1000 MG / sitagliptin 100 MG Extended Release Oral Tablet [Zituvimet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2696288 | metformin hydrochloride 1000 MG / sitagliptin 100 MG Extended Release Oral Tablet [Zituvimet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2696360 | Human tetanus immunoglobulin 250 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696360 | Human tetanus immunoglobulin 250 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696362 | Phenylephrine (as phenylephrine hydrochloride) 50 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696362 | Phenylephrine (as phenylephrine hydrochloride) 50 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696364 | Atropine sulfate 200 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696364 | Atropine sulfate 200 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696367 | Product containing precisely somatropin 4 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696367 | Product containing precisely somatropin 4 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696368 | Anakinra 149 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696368 | Anakinra 149 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696370 | Alprostadil 10 microgram powder for solution for injection cartridge | Designated preferred name (PT) | NO | |
| RxCUI: 2696370 | Alprostadil 10 microgram powder for solution for injection cartridge | Full form of descriptor (FN) | NO | |
| RxCUI: 2696372 | Dupilumab 175.439 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696372 | Dupilumab 175.439 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696374 | Bemiparin sodium 40000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696374 | Bemiparin sodium 40000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696376 | Bemiparin sodium 22500 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696376 | Bemiparin sodium 22500 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696378 | Product containing precisely tildrakizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696378 | Product containing precisely tildrakizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696380 | Product containing precisely ritonavir 100 milligram/1 sachet powder for conventional release oral suspension (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2696380 | Product containing precisely ritonavir 100 milligram/1 sachet powder for conventional release oral suspension (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2696381 | Atropine sulfate 100 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696381 | Atropine sulfate 100 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696382 | Insulin degludec 200 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2696382 | Insulin degludec 200 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2696552 | glyceryl triacetyl 12-hydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2696875 | repotrectinib 160 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2696876 | repotrectinib 160 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696876 | repotrectinib 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696877 | repotrectinib 160 MG [Augtyro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2696878 | Augtyro 160 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696878 | Augtyro 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696878 | Augtyro 160 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2696879 | ethinyl estradiol / norethindrone Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2696880 | ethinyl estradiol / norethindrone Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2696883 | ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696883 | ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696884 | inert ingredients Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2696885 | inert ingredients Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2696886 | inert ingredients 1 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696886 | inert ingredients 1 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2696887 | ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2696887 | ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696887 | ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696888 | FEMLYV 24 ODT 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2696888 | FEMLYV 24 ODT 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2696888 | FEMLYV 24 ODT 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2696971 | Momordica charantia stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697039 | disodium oxaloacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2697040 | Beizray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2697041 | docetaxel 20 MG/ML [Beizray] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697041 | docetaxel 20 MG/ML [Beizray] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697042 | Beizray Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697043 | docetaxel Injection [Beizray] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697043 | docetaxel Injection [Beizray] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697044 | BEIZRAY 80 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697044 | BEIZRAY 80 MG in 4 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697044 | BEIZRAY 80 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697044 | BEIZRAY 80 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697045 | BEIZRAY 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697045 | BEIZRAY 20 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697045 | BEIZRAY 20 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697045 | BEIZRAY 20 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2697131 | calcium lactate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2697132 | marstacimab-hncq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2697133 | marstacimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2697134 | marstacimab-hncq 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2697135 | marstacimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2697136 | marstacimab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2697139 | marstacimab-hncq 150 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697139 | marstacimab-hncq 150 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697139 | marstacimab-hncq 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697140 | marstacimab-hncq 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2697141 | Hympavzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2697142 | marstacimab-hncq 150 MG/ML [Hympavzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697143 | Hympavzi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697144 | marstacimab Auto-Injector [Hympavzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697146 | HYMPAVZI 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697146 | HYMPAVZI 150 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697146 | HYMPAVZI 150 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697146 | HYMPAVZI 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697147 | marstacimab-hncq 150 MG/ML Auto-Injector [Hympavzi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697147 | marstacimab-hncq 150 MG/ML Auto-Injector [Hympavzi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697148 | marstacimab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2697150 | marstacimab-hncq 150 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2697150 | marstacimab-hncq 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697150 | marstacimab-hncq 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697151 | marstacimab-hncq 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2697152 | marstacimab Prefilled Syringe [Hympavzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2697154 | HYMPAVZI 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697154 | HYMPAVZI 150 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697154 | HYMPAVZI 150 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697154 | HYMPAVZI 150 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697155 | marstacimab-hncq 150 MG/ML Prefilled Syringe [Hympavzi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697155 | marstacimab-hncq 150 MG/ML Prefilled Syringe [Hympavzi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697156 | aripiprazole Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2697156 | aripiprazole Oral Film Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697157 | aripiprazole Oral Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2697157 | aripiprazole Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697158 | ARIPiprazole 2 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697158 | ARIPiprazole 2 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697158 | ARIPiprazole 2 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697159 | Opipza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2697160 | aripiprazole 2 MG [Opipza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697160 | aripiprazole 2 MG [Opipza] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697161 | Opipza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697162 | Opipza Oral Film Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697163 | aripiprazole Oral Film [Opipza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697163 | aripiprazole Oral Film [Opipza] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697164 | OPIPZA 2 MG Oral Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697164 | OPIPZA 2 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697164 | OPIPZA 2 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697164 | OPIPZA 2 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697165 | ARIPiprazole 5 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697165 | ARIPiprazole 5 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697165 | ARIPiprazole 5 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697166 | aripiprazole 5 MG [Opipza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697166 | aripiprazole 5 MG [Opipza] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697167 | OPIPZA 5 MG Oral Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697167 | OPIPZA 5 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697167 | OPIPZA 5 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697167 | OPIPZA 5 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697168 | ARIPiprazole 10 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697168 | ARIPiprazole 10 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697168 | ARIPiprazole 10 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697169 | aripiprazole 10 MG [Opipza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697169 | aripiprazole 10 MG [Opipza] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697170 | OPIPZA 10 MG Oral Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697170 | OPIPZA 10 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697170 | OPIPZA 10 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697170 | OPIPZA 10 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697172 | cottonseed acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2697173 | metabisulfite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | Designated preferred name (PT) | NO | |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | Full form of descriptor (FN) | NO | |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26973 | HLA - Human leukocyte antigen A10 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | Designated preferred name (PT) | NO | |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 26974 | Human leukocyte antigen HLA-A11 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697439 | isostearamidopropyl dimethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697440 | Kesium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2697441 | amoxicillin 100 MG / clavulanate 25 MG [Kesium] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697442 | Kesium Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697443 | Kesium Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697444 | Kesium Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697445 | amoxicillin / clavulanate Chewable Tablet [Kesium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2697446 | Kesium 100 MG / 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697446 | Kesium 100 MG / 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697446 | Kesium 100 MG / 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697447 | amoxicillin 200 MG / clavulanate 50 MG [Kesium] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697448 | Kesium 200 MG / 50 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697448 | Kesium 200 MG / 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697448 | Kesium 200 MG / 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697449 | amoxicillin 300 MG / clavulanate 75 MG [Kesium] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697450 | Kesium 300 MG / 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697450 | Kesium 300 MG / 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697450 | Kesium 300 MG / 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697451 | amoxicillin 50 MG / clavulanate 12.5 MG [Kesium] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697452 | Kesium 50 MG / 12.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697452 | Kesium 50 MG / 12.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697452 | Kesium 50 MG / 12.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697453 | Sevospire | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2697454 | sevoflurane 1000 MG/ML [Sevospire] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697455 | Sevospire Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697456 | sevoflurane Inhalation Solution [Sevospire] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2697457 | Sevospire 100 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697457 | Sevospire 100 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697457 | Sevospire 100 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697457 | Sevospire 100 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697461 | Salvia officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697463 | Cnidium monnieri fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Designated preferred name (PT) | NO | |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Full form of descriptor (FN) | NO | |
| RxCUI: 26975 | HLA - Human leukocyte antigen A24(9) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Designated preferred name (PT) | NO | |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Full form of descriptor (FN) | NO | |
| RxCUI: 26976 | HLA - Human leukocyte antigen A25(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Designated preferred name (PT) | NO | |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Full form of descriptor (FN) | NO | |
| RxCUI: 26977 | HLA - Human leukocyte antigen A26(10) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697715 | pimobendan 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2697716 | pimobendan Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2697717 | pimobendan Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2697718 | pimobendan 1.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697718 | pimobendan 1.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697718 | pimobendan 1.5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2697719 | pimobendan 1.5 MG/ML [Vetmedin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2697720 | Vetmedin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697721 | pimobendan Oral Solution [Vetmedin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2697722 | Vetmedin 1.5 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2697722 | Vetmedin 1.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697722 | Vetmedin 1.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697722 | Vetmedin 1.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697732 | Carya tomentosa bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697736 | treprostinil 0.08 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2697737 | treprostinil 80 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697737 | treprostinil 80 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697737 | treprostinil 80 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697738 | treprostinil 0.08 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2697739 | TYVASO DPI 80 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697739 | TYVASO DPI 80 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697739 | TYVASO DPI 80 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697739 | TYVASO DPI 80 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697740 | salicylic acid 1.85 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697740 | salicylic acid 1.85 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697740 | salicylic acid 1.85 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2697764 | Saccharomyces boulardii Powder for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2697765 | Saccharomyces boulardii 250 MG Powder for Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2697765 | Saccharomyces boulardii 250 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697765 | Saccharomyces boulardii 250 MG Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2697765 | Saccharomyces boulardii 250 MG Powder for Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2697766 | Saccharomyces boulardii Powder for Oral Suspension [Florastor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697767 | FlorastorKids 250 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2697767 | FlorastorKids 250 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2697767 | FlorastorKids 250 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2697769 | Cervidil Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697770 | dinoprostone Vaginal Insert [Cervidil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697773 | lamotrigine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2697773 | lamotrigine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697774 | lamotrigine Tablet for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2697774 | lamotrigine Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697776 | Lamictal Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2697776 | Lamictal Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697777 | lamotrigine Tablet for Oral Suspension [Lamictal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2697777 | lamotrigine Tablet for Oral Suspension [Lamictal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2697783 | fosfomycin Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2697784 | fosfomycin Granules for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2697786 | Monurol Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2697787 | fosfomycin Granules for Oral Solution [Monurol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2697789 | Cefuroxime (as cefuroxime sodium) 250 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2697789 | Cefuroxime (as cefuroxime sodium) 250 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2697790 | Clarithromycin 500 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2697790 | Clarithromycin 500 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2697791 | Insulin lispro 25 unit/mL and insulin lispro protamine 75 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2697791 | Insulin lispro 25 unit/mL and insulin lispro protamine 75 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2697792 | Human isophane insulin 70 unit/mL and recombinant human soluble insulin 30 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2697792 | Human isophane insulin 70 unit/mL and recombinant human soluble insulin 30 unit/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697792 | Human isophane insulin 70 unit/mL and recombinant human soluble insulin 30 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2697793 | Insulin lispro 50 unit/mL and insulin lispro protamine 50 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2697793 | Insulin lispro 50 unit/mL and insulin lispro protamine 50 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | Designated preferred name (PT) | NO | |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | Full form of descriptor (FN) | NO | |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26978 | HLA - Human leukocyte antigen A28 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697821 | Agrimonia pilosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697830 | camphor 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2697831 | camphor 0.4 % / menthol 0.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2697831 | camphor 0.4 % / menthol 0.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697831 | camphor 0.4 % / menthol 0.8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Designated preferred name (PT) | NO | |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Full form of descriptor (FN) | NO | |
| RxCUI: 26979 | HLA - Human leukocyte antigen A29(19) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2697963 | Cardiospermum halicacabum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2697971 | Sauromatum giganteum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2697972 | Wolfiporia cocos sclerotium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | Designated preferred name (PT) | NO | |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | Full form of descriptor (FN) | NO | |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26980 | HLA - Human leukocyte antigen A9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2698019 | octoxynol-13 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698020 | polyacrylate crosspolymer-6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698077 | alpha-ethyl-3,4-methylenedioxybenzylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26981 | Human leucocyte antigen Aw19 | Designated preferred name (PT) | NO | |
| RxCUI: 26981 | Human leucocyte antigen Aw19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26981 | Human leucocyte antigen Aw19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26981 | Human leucocyte antigen Aw19 | Full form of descriptor (FN) | NO | |
| RxCUI: 2698135 | sodium oxybate 28-Day Starter Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2698135 | sodium oxybate 28-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698135 | sodium oxybate 28-Day Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698136 | Lumryz 28-Day Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2698136 | Lumryz 28-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698136 | Lumryz 28-Day Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698195 | obecabtagene autoleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698197 | pentapeptide-59 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2698198 | zanidatamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698199 | tigolaner | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2698200 | zanidatamab-hrii | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2698201 | zanidatamab-hrii 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698202 | zanidatamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698203 | zanidatamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2698206 | zanidatamab-hrii 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698206 | zanidatamab-hrii 300 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698207 | Ziihera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2698208 | zanidatamab-hrii 300 MG [Ziihera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698209 | Ziihera Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698210 | zanidatamab Injection [Ziihera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2698212 | ZIIHERA 300 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698212 | ZIIHERA 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698212 | ZIIHERA 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698214 | menthol 4 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698214 | menthol 4 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2698214 | menthol 4 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2698219 | dextrose 10 % in 250 ML Injection, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698219 | dextrose 10 % in 250 ML Injection, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698219 | dextrose 10 % in 250 ML Injection, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698220 | dextrose 5 % in 250 ML Injection, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698220 | dextrose 5 % in 250 ML Injection, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698220 | dextrose 5 % in 250 ML Injection, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698221 | dextrose 5 % in 1000 ML Injection, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698221 | dextrose 5 % in 1000 ML Injection, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698221 | dextrose 5 % in 1000 ML Injection, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698222 | dextrose 5 % / sodium chloride 0.9 % in 1000 ML Injection, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698222 | dextrose 5 % / sodium chloride 0.9 % in 1000 ML Injection, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698222 | dextrose 5 % / sodium chloride 0.9 % in 1000 ML Injection, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698222 | dextrose 5 % / sodium chloride 0.9 % in 1000 ML Injection, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698312 | acoramidis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698313 | acoramidis hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2698314 | acoramidis 356 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698315 | acoramidis Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698316 | acoramidis Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698317 | acoramidis Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2698318 | acoramidis 356 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698318 | acoramidis 356 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698318 | acoramidis 356 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698319 | Attruby | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2698320 | acoramidis 356 MG [Attruby] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698321 | Attruby Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698322 | Attruby Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698323 | acoramidis Oral Tablet [Attruby] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2698324 | Attruby 356 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698324 | Attruby 356 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698324 | Attruby 356 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698325 | revumenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698326 | revumenib citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2698327 | revumenib 110 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698328 | revumenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698329 | revumenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698330 | revumenib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2698331 | revumenib 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698331 | revumenib 110 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698331 | revumenib 110 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698332 | Revuforj | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2698333 | revumenib 110 MG [Revuforj] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698334 | Revuforj Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698335 | Revuforj Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698336 | revumenib Oral Tablet [Revuforj] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2698337 | Revuforj 110 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698337 | Revuforj 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698337 | Revuforj 110 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698338 | revumenib 160 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698339 | revumenib 160 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698339 | revumenib 160 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698339 | revumenib 160 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698340 | revumenib 160 MG [Revuforj] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698341 | Revuforj 160 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698341 | Revuforj 160 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698341 | Revuforj 160 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698342 | revumenib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698343 | revumenib 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698343 | revumenib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698343 | revumenib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698344 | revumenib 25 MG [Revuforj] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698345 | Revuforj 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698345 | Revuforj 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698345 | Revuforj 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698346 | dodecylhexadecyltrimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2698548 | cevimeline hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2698550 | Davallia divaricata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2698552 | Cistanche salsa stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2698555 | camphor 4.7 % / eucalyptus oil 1 % / menthol 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2698555 | camphor 4.7 % / eucalyptus oil 1 % / menthol 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698555 | camphor 4.7 % / eucalyptus oil 1 % / menthol 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2698556 | Enropro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2698561 | nilotinib tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2698562 | nilotinib 71 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698563 | nilotinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2698564 | nilotinib 71 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698564 | nilotinib 71 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698564 | nilotinib 71 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698565 | Danziten | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2698566 | nilotinib 71 MG [Danziten] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698567 | Danziten Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698568 | Danziten Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698569 | nilotinib Oral Tablet [Danziten] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2698570 | Danziten 71 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698570 | Danziten 71 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698570 | Danziten 71 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698571 | nilotinib 95 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698572 | nilotinib 95 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698572 | nilotinib 95 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698572 | nilotinib 95 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698573 | nilotinib 95 MG [Danziten] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698574 | Danziten 95 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698574 | Danziten 95 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698574 | Danziten 95 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Designated preferred name (PT) | NO | |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26986 | HLA - Human leukocyte antigen A68(28) | Full form of descriptor (FN) | NO | |
| RxCUI: 2698689 | risperidone 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2698689 | risperidone 100 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698690 | risperiDONE 100 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698690 | risperiDONE 100 MG Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2698690 | risperiDONE 100 MG Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698691 | Risvan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2698692 | risperidone 100 MG [Risvan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2698692 | risperidone 100 MG [Risvan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698693 | Risvan Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2698694 | risperidone Prefilled Syringe [Risvan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2698694 | risperidone Prefilled Syringe [Risvan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698695 | RISVAN 100 MG Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2698695 | RISVAN 100 MG Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698695 | RISVAN 100 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698695 | RISVAN 100 MG Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | Designated preferred name (PT) | NO | |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | Full form of descriptor (FN) | NO | |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26987 | HLA - Human leukocyte antigen B12 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2698721 | risperidone 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2698721 | risperidone 75 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698722 | risperiDONE 75 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698722 | risperiDONE 75 MG Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2698722 | risperiDONE 75 MG Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698723 | risperidone 75 MG [Risvan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2698723 | risperidone 75 MG [Risvan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698724 | RISVAN 75 MG Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2698724 | RISVAN 75 MG Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2698724 | RISVAN 75 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2698724 | RISVAN 75 MG Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2698762 | eladocagene exuparvovec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2698763 | dextrose 50 % Injectable Solution, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698763 | dextrose 50 % Injectable Solution, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698763 | dextrose 50 % Injectable Solution, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698764 | dextrose 70 % Injectable Solution, Shortage Import Unapproved | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698764 | dextrose 70 % Injectable Solution, Shortage Import Unapproved | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698764 | dextrose 70 % Injectable Solution, Shortage Import Unapproved | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698765 | eladocagene exuparvovec-tneq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2698766 | eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2698767 | eladocagene exuparvovec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2698768 | eladocagene exuparvovec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2698771 | eladocagene exuparvovec-tneq 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2698771 | eladocagene exuparvovec-tneq 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698771 | eladocagene exuparvovec-tneq 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698772 | eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2698773 | Kebilidi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2698774 | eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML [Kebilidi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2698775 | Kebilidi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2698776 | eladocagene exuparvovec Injection [Kebilidi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2698778 | Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2698778 | Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698778 | Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2698778 | Kebilidi 560,000,000,000 VECTOR-GENOMES in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2698779 | eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection [Kebilidi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2698779 | eladocagene exuparvovec-tneq 560000000000 VECTOR-GENOMES/ML Injection [Kebilidi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | Designated preferred name (PT) | NO | |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26988 | HLA - Human leukocyte antigen B13 | Full form of descriptor (FN) | NO | |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | Designated preferred name (PT) | NO | |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26989 | HLA - Human leukocyte antigen B14 | Full form of descriptor (FN) | NO | |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | Designated preferred name (PT) | NO | |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | Full form of descriptor (FN) | NO | |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26990 | HLA - Human leukocyte antigen B15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699081 | menthol 7.6 MG [Therastat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2699082 | THERASTAT 7.6 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699082 | THERASTAT 7.6 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699082 | THERASTAT 7.6 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | Designated preferred name (PT) | NO | |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26991 | HLA - Human leukocyte antigen B16 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699121 | bimekizumab-bkzx 320 MG in 2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699121 | bimekizumab-bkzx 320 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699121 | bimekizumab-bkzx 320 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699122 | Bimzelx 320 MG in 2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699122 | Bimzelx 320 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699122 | Bimzelx 320 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699123 | bimekizumab-bkzx 320 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699123 | bimekizumab-bkzx 320 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699123 | bimekizumab-bkzx 320 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699124 | Bimzelx 320 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699124 | Bimzelx 320 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699124 | Bimzelx 320 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699125 | PEG-40 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2699126 | camphor 0.0025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2699127 | glycerin 0.223 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2699128 | camphor / glycerin Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2699129 | camphor 0.25 % / glycerin 22.25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2699129 | camphor 0.25 % / glycerin 22.25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699129 | camphor 0.25 % / glycerin 22.25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699129 | camphor 0.25 % / glycerin 22.25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Designated preferred name (PT) | NO | |
| RxCUI: 26992 | Blood group antigen Bg^b^ | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26992 | Blood group antigen Bg^b^ | Full form of descriptor (FN) | NO | |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | Designated preferred name (PT) | NO | |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26993 | HLA - Human leukocyte antigen B18 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699307 | Chenopodium quinoa seedcake extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2699311 | dextromethorphan / pseudoephedrine / triprolidine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2699313 | dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699313 | dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699313 | dextromethorphan HBr 15 MG / pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699315 | adalimumab-aacf 40 MG in 0.8 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699315 | adalimumab-aacf 40 MG in 0.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699315 | adalimumab-aacf 40 MG in 0.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699316 | adalimumab-aacf 50 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699316 | adalimumab-aacf 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2699317 | adalimumab Injection [Idacio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699319 | Idacio 40 MG in 0.8 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699319 | Idacio 40 MG in 0.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699319 | Idacio 40 MG in 0.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699320 | Idacio 50 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699320 | Idacio 50 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699320 | Idacio 50 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699321 | dimethyl sulfoxide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2699322 | dimethyl sulfoxide / miconazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2699323 | dimethyl sulfoxide / miconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2699324 | dimethyl sulfoxide / miconazole Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2699327 | dimethyl sulfoxide 2 % / miconazole nitrate 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699327 | dimethyl sulfoxide 2 % / miconazole nitrate 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699327 | dimethyl sulfoxide 2 % / miconazole nitrate 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699328 | Fungizyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699329 | dimethyl sulfoxide 20 MG/ML / miconazole nitrate 20 MG/ML [Fungizyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699330 | Fungizyl Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699331 | dimethyl sulfoxide / miconazole Topical Cream [Fungizyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699333 | Fungizyl AC 2 % / 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699333 | Fungizyl AC 2 % / 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699333 | Fungizyl AC 2 % / 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699334 | pemetrexed dipotassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2699334 | pemetrexed dipotassium | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2699335 | Axtle | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699336 | pemetrexed 100 MG [Axtle] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699336 | pemetrexed 100 MG [Axtle] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699337 | Axtle Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699338 | pemetrexed Injection [Axtle] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699338 | pemetrexed Injection [Axtle] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699339 | AXTLE 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699339 | AXTLE 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699339 | AXTLE 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699339 | AXTLE 100 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699340 | pemetrexed 500 MG [Axtle] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699340 | pemetrexed 500 MG [Axtle] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699341 | AXTLE 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699341 | AXTLE 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699341 | AXTLE 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699341 | AXTLE 500 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699342 | paliperidone palmitate 351 MG in 2.25 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699342 | paliperidone palmitate 351 MG in 2.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699342 | paliperidone palmitate 351 MG in 2.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699342 | paliperidone palmitate 351 MG in 2.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699343 | Erzofri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699344 | paliperidone palmitate 156 MG/ML [Erzofri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699345 | Erzofri Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699346 | paliperidone Prefilled Syringe [Erzofri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699348 | Erzofri 351 MG in 2.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699348 | Erzofri 351 MG in 2.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699348 | Erzofri 351 MG in 2.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699348 | Erzofri 351 MG in 2.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699349 | Erzofri 156 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699349 | Erzofri 156 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699349 | Erzofri 156 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699350 | Erzofri 117 MG in 0.75 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699350 | Erzofri 117 MG in 0.75 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699350 | Erzofri 117 MG in 0.75 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699350 | Erzofri 117 MG in 0.75 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699351 | Erzofri 156 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699351 | Erzofri 156 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699351 | Erzofri 156 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699351 | Erzofri 156 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699352 | Erzofri 234 MG in 1.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699352 | Erzofri 234 MG in 1.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699352 | Erzofri 234 MG in 1.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699352 | Erzofri 234 MG in 1.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699353 | Erzofri 39 MG in 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699353 | Erzofri 39 MG in 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699353 | Erzofri 39 MG in 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699353 | Erzofri 39 MG in 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699354 | Erzofri 78 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699354 | Erzofri 78 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699354 | Erzofri 78 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699354 | Erzofri 78 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699355 | ascorbic acid 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699355 | ascorbic acid 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699355 | ascorbic acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699355 | ascorbic acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699386 | menthol 9 MG [Thoracol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2699387 | THORACOL 9 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699387 | THORACOL 9 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699387 | THORACOL 9 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699388 | menthol 8.6 MG [Thoracol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2699389 | THORACOL 8.6 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699389 | THORACOL 8.6 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699389 | THORACOL 8.6 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | Designated preferred name (PT) | NO | |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26994 | HLA - Human leukocyte antigen B37 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699422 | methyl phenylacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699424 | methylcyclopentenolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699483 | activated charcoal 104 MG/ML [Insta-Char] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699484 | Insta-Char 104 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699484 | Insta-Char 104 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699484 | Insta-Char 104 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699484 | Insta-Char 104 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699485 | sodium fluoride 0.00315 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2699486 | potassium nitrate 5 % / sodium fluoride 0.315 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699486 | potassium nitrate 5 % / sodium fluoride 0.315 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699486 | potassium nitrate 5 % / sodium fluoride 0.315 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2699486 | potassium nitrate 5 % / sodium fluoride 0.315 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699486 | potassium nitrate 5 % / sodium fluoride 0.315 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699487 | tulathromycin 25 MG/ML [Vacasan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2699488 | VACASAN 25 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699488 | VACASAN 25 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699488 | VACASAN 25 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699489 | Levothyroxine sodium 250 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2699489 | Levothyroxine sodium 250 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | Designated preferred name (PT) | NO | |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26995 | HLA - Human leukocyte antigen B40 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699580 | Corydalis solida whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699581 | Euphorbia kansui whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699587 | zenocutuzumab-zbco | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2699588 | zenocutuzumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2699589 | zenocutuzumab-zbco 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2699590 | zenocutuzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2699591 | zenocutuzumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2699594 | zenocutuzumab-zbco 375 MG in 18.75 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699594 | zenocutuzumab-zbco 375 MG in 18.75 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699594 | zenocutuzumab-zbco 375 MG in 18.75 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699595 | zenocutuzumab-zbco 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699595 | zenocutuzumab-zbco 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2699596 | Bizengri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699597 | zenocutuzumab-zbco 20 MG/ML [Bizengri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699598 | Bizengri Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699599 | zenocutuzumab Injection [Bizengri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 26996 | Human leucocyte antigen B44 | Designated preferred name (PT) | NO | |
| RxCUI: 26996 | Human leucocyte antigen B44 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26996 | Human leucocyte antigen B44 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26996 | Human leucocyte antigen B44 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699601 | Bizengri 375 MG in 18.75 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699601 | Bizengri 375 MG in 18.75 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699601 | Bizengri 375 MG in 18.75 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699602 | Bizengri 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699602 | Bizengri 20 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699602 | Bizengri 20 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699611 | Minzoya 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2699611 | Minzoya 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699611 | Minzoya 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699612 | Raldesy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699613 | trazodone hydrochloride 10 MG/ML [Raldesy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699613 | trazodone hydrochloride 10 MG/ML [Raldesy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699614 | Raldesy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699615 | Raldesy Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699616 | trazodone Oral Solution [Raldesy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699616 | trazodone Oral Solution [Raldesy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699617 | trazodone hydrochloride Oral Solution [Raldesy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699618 | RALDESY 10 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699618 | RALDESY 10 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699618 | RALDESY 10 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699618 | RALDESY 10 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2699657 | phosphate ion(2-) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2699658 | sodium chloride 0.9 % in 3000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699658 | sodium chloride 0.9 % in 3000 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699658 | sodium chloride 0.9 % in 3000 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699658 | sodium chloride 0.9 % in 3000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699678 | polyglyceryl-4 palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699679 | Typha angustifolia stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | Designated preferred name (PT) | NO | |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26997 | HLA - Human leukocyte antigen B5 | Full form of descriptor (FN) | NO | |
| RxCUI: 2699765 | Coix lacryma-jobi whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2699820 | camphor 3.5 % / menthol 6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2699820 | camphor 3.5 % / menthol 6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699820 | camphor 3.5 % / menthol 6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699821 | Arcticzen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2699822 | camphor 0.035 MG/MG / menthol 0.06 MG/MG [Arcticzen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2699823 | Arcticzen Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2699824 | camphor / menthol Medicated Patch [Arcticzen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2699825 | ARCTICZEN 3.5 % / 6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2699825 | ARCTICZEN 3.5 % / 6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2699825 | ARCTICZEN 3.5 % / 6 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2699826 | fenoprofen Oral Capsule [Fenopron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699827 | Fenopron 300 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699827 | Fenopron 300 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699827 | Fenopron 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699828 | imatinib 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2699829 | imatinib Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2699830 | imatinib Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2699831 | imatinib 80 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699831 | imatinib 80 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699831 | imatinib 80 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2699832 | Imkeldi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2699833 | imatinib 80 MG/ML [Imkeldi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2699834 | Imkeldi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699835 | Imkeldi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2699836 | imatinib Oral Solution [Imkeldi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2699837 | Imkeldi 80 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2699837 | Imkeldi 80 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2699837 | Imkeldi 80 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2699837 | Imkeldi 80 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
